Adino Life Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 14 Year, 2 Months
- Last Filing with ROC 31 Mar 2016
About Adino Life Pharmaceuticals
Adino Life Pharmaceuticals Private Limited (ALPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 November 2010 and has a history of 14 years and two months. Its registered office is in Patna, Bihar, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Pritesh Kumar, Prem Narayan, Mritunjay Kumar, and One other member serve as directors at the Company.
Company Details
-
Location
Patna, Bihar, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74900BR2010PTC016255
-
Company No.
016255
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Nov 2010
-
Date of AGM
30 Sep 2016
-
Date of Balance Sheet
31 Mar 2016
-
Listing Status
Unlisted
-
ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Adino Life Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prem Narayan
|
Managing Director | 18-Nov-2010 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Pritesh Kumar
|
Director | 18-Nov-2010 | Current |
|
Mritunjay Kumar
|
Director | 06-Sep-2011 | Current |
|
Rajesh Kumar
|
Director | 06-Sep-2011 | Current |
Financial Performance of Adino Life Pharmaceuticals.
Enhance accessibility to Adino Life Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adino Life Pharmaceuticals?
In 2016, Adino Life Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Solvelife Pharmaceuticals Private LimitedPritesh Kumar is a mutual person
-
Artis Healthcare Private Limited
Mritunjay Kumar is a mutual person
-
Krypton Remedies Private Limited
Rajesh Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Adino Life Pharmaceuticals?
Unlock and access historical data on people associated with Adino Life Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adino Life Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adino Life Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
